Biberach, Germany

Dirk Stenkamp

USPTO Granted Patents = 50 


 

Average Co-Inventor Count = 8.2

ph-index = 9

Forward Citations = 266(Granted Patents)

Forward Citations (Not Self Cited) = 240(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Birberach, DE (2002)
  • Biberach, DE (2004 - 2015)
  • Biberach an der Riss, DE (2013 - 2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
Loading Chart...
50 patents (USPTO):Explore Patents

Title: Innovator in Pharmaceutical Sciences: Dirk Stenkamp

Introduction

Dirk Stenkamp, a prominent inventor located in Biberach, Germany, has made significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 50 patents, Stenkamp’s work focuses on developing innovative compounds that address critical health issues.

Latest Patents

One of Stenkamp's latest patents includes the development of 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives. These pharmaceutical compositions possess valuable pharmacological activity, particularly as agonists of the 5-HT2C receptor, making them suitable for treating and preventing diseases influenced by receptor inhibition, such as metabolic and CNS-related disorders. Additionally, his patent on 1H-benzimidazole-5-carboxamides highlights their potential as anti-inflammatory agents. These compounds aim to inhibit the activity of members of the MAPEG family, making them valuable in treating inflammation and cancer.

Career Highlights

Stenkamp has dedicated a substantial portion of his career to influential companies in the pharmaceutical industry. He has worked for Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG, where he has contributed to various innovative projects that underscore his expertise in drug development.

Collaborations

Throughout his career, Dirk Stenkamp has collaborated with notable professionals, including colleagues Klaus Rudolf and Stephan Georg Mueller. These partnerships have further enhanced the innovation and successful implementation of his ideas within the pharmaceutical landscape.

Conclusion

With his impressive number of patents and groundbreaking research, Dirk Stenkamp exemplifies the spirit of innovation in the pharmaceutical sector. His latest work continues to pave the way for advancements that may significantly impact the treatment of various health conditions. Stenkamp's dedication and collaborative spirit reflect the ongoing evolution of medical science and the importance of inventive contributions in this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…